Therefore, we focused on the occurrence of AAbs in 2453 patients whose sera were evaluated for anti-retinal Aabs; consequently, the sample of patients with breast cancer, vision disturbance, and anti-TULP1 is relatively small. This evidence concerns the gene TULP1 and breast cancer.